Navigation Links
Vermillion Reports Third Quarter 2013 Results
Date:11/14/2013

AUSTIN, Texas, Nov. 14, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its financial results for the third quarter ended September 30, 2013.

Q3 2013 Financial Results
Total revenue in the third quarter of 2013 was $330,000 compared to $319,000 in the same year-ago quarter. Third quarter 2013 revenue was comprised of $216,000 in OVA1® product sales and $114,000 in license revenue.

Third quarter of 2013 product revenue was derived from 4,328 OVA1 tests performed at the fixed $50 per test as reported by Quest Diagnostics. This represents a 5.6% increase in test volume compared to approximately 4,100 OVA1 tests performed in the year-ago quarter. Although covered lives have decreased to approximately 67.0 million due to the previously announced BlueCross BlueShield Technical Evaluation Center position, it did not affect test sale volumes for the quarter.

The OVA1 product revenue in both periods does not include the additional royalty component of revenue based on 33% of Quest Diagnostics gross margin. Vermillion recognizes this portion of revenue when it is reported by Quest Diagnostics in an annual 'true-up' after the end of the calendar year. The true-up is based on reimbursed and unreimbursed tests for which Quest Diagnostics considers the payment status as final.

Total operating expenses were $2.6 million in both the third quarter of 2013 and the same year-ago quarter. For the nine months ended September 30, 2013, total operating expenses were $7.9 million as compared to $9.0 million in the same year-ago period.

Net loss for the third quarter was $2.3 million or $(0.10) per share, as compared to a net loss of $2.0 million or $(0.13) per share in the same year-ago quarter. For the nine months ended September 30, 2013, net loss was $7.0 million or $(0.36) per share as compared to a net loss of $5.8 million or $(0.39
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
2. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
3. Vermillion Sets Third Quarter 2013 Conference Call for Thursday, November 14, 2013
4. Vermillion Appoints Dr. Eric Varma to its Board of Directors
5. Vermillion Supports First World Ovarian Cancer Day and Effort to Raise Awareness of the Need for Better Diagnosis and Treatment
6. Vermillion Sets First Quarter 2013 Conference Call for Wednesday, May 15, 2013
7. Vermillion Appoints Thomas McLain as President and Chief Executive Officer
8. Vermillion Reports Fourth Quarter and Full Year 2012 Results
9. Vermillion to Discuss Preliminary Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013, at 4:30 p.m. ET
10. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
11. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... present at the following conferences in May 2015: ... ,Date:            May 10, ... Officer ,Time:            1:45 ...
(Date:5/5/2015)... , May 5, 2015 ... or the "Company"), a premier provider of innovative medical ... today issued an update to shareholders and the investment ... financing and acquisition of the proprietary Bioelectrical Signal Therapy™ ... completion of its S-1, as well as its plans ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Clinical Laboratory,Molecular Diagnostics and Genomic ... 2019 - Asia Pacific Version" report to ... keeps on growing. Clinical laboratory testing is positioned ... especially genomics. A range of dynamic trends are ...
Breaking Medicine Technology:Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2
... 21, 2011 Dr. Kaveh Kardooni joins ... in Neuroradiology. Dr. Kardooni graduated from the ... science in biology. He received his medical degree from ... Kardooni completed his diagnostic radiology residency in 2009 at ...
... (Nasdaq: NBIX ) announced today that the Company ... Nasdaq market closes on Thursday, July 28, 2011. Neurocrine will ... its financial results and provide a Company update Friday morning, ... Pacific Time). Participants can access the live conference ...
Cached Medicine Technology:Desert Radiologists Welcomes Dr. Kaveh Kardooni 2
(Date:5/5/2015)... Oklahoma (PRWEB) May 05, 2015 Don’t ... the money for a fitness membership? Don’t know which ... of these obstacles in order to help members achieve ... life. Live Streaming Fitness, an educational, caused-based wellness company, ... offers live streaming fitness classes led by certified trainers, ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... 29th and honored Walt “Clyde” Frazier and Cravath, Swaine ... of New York’s highest-need communities. The event was co-chaired ... Saul Kupferberg. , “The Next Chapter” highlighted Sheltering Arms’ ... name, which was unveiled in February 2015. Formerly Episcopal ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Buckeye Health ... the new CEO and plan president of Buckeye Health ... assumes the position immediately. , Hill has more than ... to the Pacific Northwest, from managed care to large ... president and CEO of HealthPlus of Michigan, a health ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 NovaSom, Inc., ... upcoming episode of Innovations with Ed Begley Jr., airing ... times TBA. , This segment will focus on NovaSom, ... Viewers will learn about their AccuSom® home sleep test, ... that provides continuous patient support and next-day test results ...
(Date:5/5/2015)... May 05, 2015 After record-breaking sales ... in 2014, Walgreens introduces the Cookies & Cream flavor ... innovation, Extend Nutrition has continually raised the bar for ... taste, combined with an unprecedented nutritional profile, backed by ... success, Extend Nutrition will launch additional new products and ...
Breaking Medicine News(10 mins):Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4
... International Association of Athletics Federation (IAAF); seeks qualification at ... ... Oscar Pistorius -- a double amputee,athlete from South Africa who competes ... before the Court of Arbitration for Sport,(CAS) in Lausanne, Switzerland challenging ...
... its risks for many patients, experts say , , WEDNESDAY, ... patients than previously thought may develop heart failure when ... The drug was approved for advanced kidney cancer and ... support a role for routine cardiac monitoring for patients ...
... Reaffirms Outlook for Continued Growth, CAMBRIDGE, Mass., Feb. 13 ... full year and,fourth quarter of 2007 and provided an outlook for ... -- Total revenue in 2007 increased 20 percent to $3.8 billion ... increase was broadly driven by growth across all ...
... Winner Medical Group,Inc. (OTC Bulletin Board: WMDG; "Winner Medical"), ... of fiscal year 2008,ended December 31, 2007. The Company,s ... the United States Securities and Exchange,Commission., First ... $19.33 million, a 21.73% year-on-year ...
... Pharmacopeia,(Nasdaq: PCOP ), an innovator in the ... that Dr. Leslie J. Browne,President and Chief Executive Officer, ... OC Growth Stock Conference. The,conference will be held February ... Point, CA., Dr. Browne,s presentation will take place ...
... third meeting -, BELLEVILLE, ON, Feb. ... BNC), a research-based, technology-driven Canadian,biopharmaceutical company, is ... progress,of its North American clinical trial with ... - in patients with non muscle-invasive,bladder cancer ...
Cached Medicine News:Health News:Oscar Pistorius Aims to Compete on Level Playing Field at 2008 Beijing Olympics 2Health News:Kidney Cancer Drug Linked to Higher Rate of Heart Problems 2Health News:Kidney Cancer Drug Linked to Higher Rate of Heart Problems 3Health News:Kidney Cancer Drug Linked to Higher Rate of Heart Problems 4Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 2Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 3Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 4Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 5Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 6Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 7Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 8Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 9Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 10Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 11Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 12Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 13Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 14Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 15Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 16Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 17Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 18Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 19Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 20Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 21Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 22Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 23Health News:Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year 24Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 2Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 3Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 4Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 5Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 6Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 7Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 8Health News:Winner Medical Reports First Quarter Fiscal 2008 Results 9
... 96 well thermocycler with unique ... technology for fastest available heating ... 4C/sec with High Pressure Lid ... plates. Includes motorized lid ...
... RoboCycler Gradient 40 or 96 temperature cyclers, the ... linear temperature range of up to 14 or ... with a temperature difference of up to 2C ... you can test up to 12 different annealing ...
... The Techne TC-512 has a graphical touch ... your experiments at the "touch of a ... Wide linear gradient, Touch Screen, Graphical Display, ... Performance, Versatile Block Format, Intuitive Programmin, Free ...
... performance, high sample throughput instrument at a highly ... Flexible block format, a newly designed flexible heated ... Includes a four year or 80,000 Cycle Warranty! ... connected and run through a PC using Gensoft, ...
Medicine Products: